Meningococcal disease: clinical presentation and sequelae, Vaccine, vol.30, issue.2, pp.3-9, 2012. ,
The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease, Vaccine, vol.29, issue.18, pp.3363-71, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02083011
MLST revisited: the gene-by-gene approach to bacterial genomics, Nat Rev Microbiol, vol.11, issue.10, pp.728-764, 2013. ,
, European Centre for Disease Prevention and Control. Factsheet about meningococcal disease, 2019.
Neisseria meningitidis: biology, microbiology, and epidemiology, Methods Mol Biol, vol.799, pp.1-20, 2012. ,
, World Health Organization. Meningococcal Meningitis: World Health Organization, 2018.
Meningococcal disease in the Middle East and Africa: findings and updates from the global meningococcal initiative, J Infect, vol.75, issue.1, pp.1-11, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02013243
Vaccines for the prevention of meningococcal capsular group B disease: what have we recently learned?, Hum Vaccin Immunother, vol.12, issue.1, pp.235-243, 2016. ,
The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations, Expert Rev Vaccines, vol.18, issue.1, pp.15-30, 2019. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02013210
Surveillance of invasive meningococcal disease based on whole genome sequencing (WGS), Epidemiol Mikrobiol Imunol, vol.67, issue.2, pp.64-73, 2015. ,
Genomic surveillance of invasive meningococcal disease in the Czech Republic, PLoS One, vol.14, issue.7, p.219477, 2015. ,
The epidemiology of invasive meningococcal disease in EU/EEA countries, Vaccine, vol.35, issue.16, pp.2034-2075, 2004. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02055716
Be on the TEAM (Teenagers Against Meningitis): a clinical trial evaluating the impact of two licensed group B meningococcal vaccines on pharyngeal carriage of meningococcus in adolescents, Proceedings of the 21st International Pathogenic Neisseria Conference, pp.23-31, 2018. ,
, Analysis of the evolution of communicable diseases. Surveillance report, 2017.
Bacterial agents causing meningitis during 2013-2014 in Turkey: a multi-center hospital-based prospective surveillance study, Hum Vaccin Immunother, vol.12, issue.11, pp.2940-2945, 2016. ,
Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae type B and Streptococcus Pneumoniae during 2005-2012 in Turkey. A multicenter prospective surveillance study, Hum Vaccin Immunother, vol.10, issue.9, pp.2706-2718, 2014. ,
, Russian Reference Center for Monitoring Bacterial Meningitis [Meningococcal infection and purulent bacterial meningitis in the Russian Federation, 2017.
, ??????????????? ???????? ? ??????? ????????????? ????????? ? ?????????? ????????? 2017 ???, 2018.
Invasive meningococcal disease (IMD) in Poland, 2018. ,
, National Center for Epidemiology The epidemiolgy of invasive meningococcal disease in Hungary, EPINFO, vol.23, issue.49, pp.593-601, 2016.
Serogroup diversity and antibiotic susceptibility of Neisseria meningitidis : meningococcus infection monitoring in Belarus, Acta Microbiol Immunol Hung, vol.2019, pp.1-7 ,
The changing epidemiology of bacterial meningitis during 2015-2017 in Turkey: a hospital-based prospective surveillance study, Open Forum Infect Dis, vol.5, 2018. ,
The distribution of serogroups causing invasive forms of meningococcal infection in Moscow, Proceedings of the XI Annual Russian Congress of Infectious Diseases with International Participation, pp.1-3, 2018. ,
,
, ??????????? -????????????? ?????????? ???????????? ???????? ?????????????? ????????? ?? ??????????? ?????, Infect Dis News, Opin Train, vol.7, issue.1, pp.93-102, 2018.
Increase of invasive meningococcal serogroup W disease in Europe, Euro Surveill, vol.24, issue.14, 2013. ,
Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, J Med Microbiol, vol.65, issue.9, pp.1013-1032, 2009. ,
Whole genome sequencing of Neisseria meningitidis W isolates from the Czech Republic recovered in 1984-2017, PLoS One, vol.13, issue.9, p.199652, 2018. ,
Czech Vaccinology Society recommendation for vaccination against invasive meningococcal disease, 2018. ,
, The federal service on customers' rights protection and human well-being surveillance prevention of meningococcus infection: the federal service on customers' rights protection and human well-being surveillance, 2018.
, National Public Health Centre. National Guideline of Vaccinaton (Hungarian), p.29, 2019.
A decade of invasive meningococcal disease surveillance in Poland, PLoS One, vol.8, issue.8, p.71943, 2013. ,
Meningococcal vaccines, pp.388-418, 2012. ,
The epidemiology of meningococcal disease and the impact of vaccines, Exp Rev Vaccines, vol.9, issue.3, pp.285-98, 2010. ,
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines, Nat Rev Immunol, vol.9, pp.213-233, 2009. ,
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity, J Infect Dis, vol.197, issue.5, pp.737-780, 2008. ,
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story, Vaccine, vol.20, issue.1, pp.58-67, 2001. ,
Effect of a serogroup a meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study, Lancet, vol.383, issue.9911, pp.40-47, 2014. ,
Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Emerg Infect Dis, vol.21, issue.1, pp.115-133, 2013. ,
Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac, BMC Infect Dis, vol.14, issue.663, pp.1-11, 2014. ,
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity, Clin Infect Dis, vol.56, issue.3, pp.354-63, 2013. ,
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial, Lancet, vol.384, issue.9960, pp.2123-2154, 2014. ,
, Any Impact on serogroup W? (up to 2016/17), 2018.
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study, Lancet Infect Dis, vol.18, issue.10, pp.1088-96, 2018. ,
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis, Lancet, vol.2, issue.8346, pp.355-362, 1983. ,
Immunologic response of man to group B meningococcal polysaccharide, J Infect Dis, vol.126, issue.5, pp.514-535, 1972. ,
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future, Hum Vaccin Immunother, vol.9, issue.6, pp.1241-53, 2013. ,
Durability of immunogenicity and strain coverage of MenBvac, a meningococcal vaccine based on outer membrane vesicles: lessons of the Normandy campaign, Vaccine, vol.35, issue.32, pp.4029-4062, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02013259
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing, Science, vol.20, issue.0, pp.1816-1836 ,
, , 2019.
, Bexsero meningococcal group B vaccine for injection in pre-filled syringe, SmPC, 2019.
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, issue.5, pp.416-441, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02093031
Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB), Vaccine, vol.32, issue.1, pp.124-154, 2013. ,
Predicting the susceptibility of meningococcal serogroup B isolates to bactericidal antibodies elicited by bivalent rLP2086, a novel prophylactic vaccine, MBio, vol.9, issue.2, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01950865
Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine, BMC Microbiol, vol.14, p.111, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00990250
High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland, Vaccine, vol.34, issue.4, pp.510-525, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02060307
Meningococcal antigen typing system (MATS) based coverage prediction for the 4CMenB vaccine in United States, Proceedings of the 18th International Pathogenic Neisseria Conference, pp.9-14, 2012. ,
Meningococcal carriage evaluation in response to a serogroup B meningococcal disease outbreak and mass vaccination campaign at a College-Rhode Island, Clin Infect Dis, vol.64, issue.8, pp.1115-1137, 2015. ,
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents, BMJ Open, vol.8, issue.7, p.20988, 2018. ,
A cluster randomised controlled trial in senior school students to assess the impact of 4CMenB on N. meningitidis carriage and determine any herd protection, Proceedings of the 21st International Pathogenic Neisseria Conference, pp.23-31, 2018. ,
A bivalent meningococcal B vaccine in adolescents and young adults, N Engl J Med, vol.377, issue.24, pp.2349-62, 2017. ,
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study, Lancet, vol.379, issue.9816, pp.617-641, 2012. ,
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials, Lancet, vol.381, issue.9869, pp.825-860, 2013. ,
Early evidence of effectiveness against group B meningococcal disease and population impact of a reduced infant schedule with 4CMenB vaccine in England, Lancet, vol.338, pp.2775-82, 2016. ,
Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study, Lancet Child Adolesc Health, vol.2, issue.6, pp.395-403, 2018. ,
A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: results of a phase 2 randomized, controlled trial, Vaccine, vol.33, issue.21, pp.2500-2510, 2015. ,
Potential coverage of the 4CMenB vaccine against invasive serogroup B Neisseria meningitidis isolated from 2009 to 2013 in the Republic of, Ireland. mSphere, vol.3, issue.4, 2018. ,
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines, Proc Natl Acad Sci, vol.107, issue.45, pp.19490-19495, 2010. ,
Genetic meningococcal antigen typing system (gMATS): a genotyping tool that predicts 4CMenB strain coverage worldwide, Vaccine, vol.37, issue.7, pp.991-1001, 2000. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02013229
Distribution of Bexsero(R) antigen sequence types (BASTs) in invasive meningococcal disease isolates: implications for immunisation, Vaccine, vol.34, issue.39, pp.4690-4697, 2016. ,
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage, Vaccine, vol.31, issue.43, pp.4-96, 2013. ,
Correlation between alterations of the penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G, J Biol Chem, vol.278, issue.34, pp.31529-31564, 2003. ,
Complete sequence of a beta-lactamase-encoding plasmid in Neisseria meningitidis, Antimicrob Agents Chemother, vol.20, issue.0, pp.210-222 ,
Penicillin-resistant Neisseria meningitidis in southern Africa, Lancet, vol.1, p.54, 1988. ,
Introductory address: resistance to antimicrobial agents. What next for Neisseria gonorrhoeae?, Sex Transm Dis, vol.11, issue.4, pp.353-362, 1984. ,
Penicillin-resistant beta-lactamase producing Neisseria meningitidis in Spain, Eur J Clin Microbiol Infect Dis, vol.8, issue.1, pp.90-91, 1989. ,
Transfer of beta-lactamase plasmids from Neisseria gonorrhoeae to Neisseria meningitidis and commensal Neisseria species by the 25.2-megadalton conjugative plasmid, Antimicrob Agents Chemother, vol.32, issue.9, pp.1430-1432, 1988. ,
Isolation of a strain of beta-lactamase-producing Neisseria meningitidis in Spain, Eur J Clin Microbiol Infect Dis, vol.15, issue.2, pp.181-183, 1996. ,
Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease, Int J Infect Dis, vol.69, pp.55-62, 2018. ,
Acquisition of beta-lactamase by Neisseria meningitidis through possible horizontal gene transfer, Antimicrob Agents Chemother, vol.62, issue.9, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01950880
Vogel U First invasive meningococcal isolate expressing a betalactamase in Germany, Proceedings of the 15th European Meningococcal and, p.35, 2019. ,
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis, Antimicrob Agents Chemother, vol.51, issue.8, pp.2784-92, 2007. ,
Emergence of meningococci with reduced susceptibility to third-generation cephalosporins, J Antimicrob Chemother, vol.72, issue.1, pp.95-103, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02013247
Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex, Science, vol.296, issue.5571, pp.1285-90, 2002. ,
Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin, Antimicrob Agents Chemother, vol.57, issue.4, pp.1961-1965, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02089320
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing, Antimicrob Agents Chemother, vol.54, issue.9, pp.3651-3659, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02085459
Ciprofloxacin-resistant Neisseria meningitidis, Emerg Infect Dis, vol.13, issue.10, pp.1614-1630, 2007. ,
Outbreak of meningococcal disease in and around, Epidemiol Infect, vol.20, issue.4, pp.570-576, 2009. ,
Direct detection and serogroup characterization of Neisseria meningitidis from outbreak of meningococcal meningitis in Delhi, Iran J Microbiol, vol.2, issue.2, pp.73-82, 2010. ,
Genetic diversity and clonal characteristics of ciprofloxacin-resistant meningococcal strains in China, J Med Microbiol, vol.63, pp.1411-1429, 2014. ,
Shifts in the antibiotic susceptibility, serogroups, and clonal complexes of Neisseria meningitidis in shanghai, china: a time trend analysis of the pre-quinolone and quinolone eras, PLoS Med, vol.12, issue.6, p.1001838, 2015. ,
Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage, J Infect, vol.71, issue.5, pp.544-52, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02013265
Whole-genome sequencing of emerging invasive Neisseria meningitidis serogroup W in sweden, J Clin Microbiol, vol.56, issue.4, pp.1409-1410, 2018. ,
Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France, J Infect, vol.76, issue.2, pp.149-58, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01950885
Temporal associations between national outbreaks of meningococcal serogroup W and c disease in the Netherlands and England: an observational cohort study, Lancet Publ Health, vol.2, issue.10, pp.473-82, 2017. ,
Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, Euro Surveill, vol.16, issue.1, 1998. ,
Frequent capsule switching in 'ultra-virulent' meningococci -Are we ready for a serogroup B ST-11 complex outbreak?, J Infect, vol.75, issue.2, pp.95-103, 2017. ,
, Defeating meningitis by 2030, Proceedings of the First Meeting of the Technical Taskforce, 2018.
Genomic characterization of urethritis-associated Neisseria meningitidis shows that a wide range of N. meningitidis strains can cause urethritis, J Clin Microbiol, vol.55, issue.12, pp.3374-83, 2017. ,
Increased risk for meningococcal disease among men who have sex with men in the United States, Clin Infect Dis, vol.65, issue.5, pp.756-63, 2012. ,
Evolutionary events associated with an outbreak of meningococcal disease in men who have sex with men, PLoS One, vol.11, issue.5, p.154047, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01351740
Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region, Euro Surveill, vol.20, issue.3, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02060707
A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, Euro Surveill, vol.18, issue.28, 2012. ,
Interconnected clusters of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11), involving bisexuals and men who have sex with men, with discos and gay-venues hotspots of transmission, Euro Surveill, vol.23, issue.34, 2015. ,
Notes from the field: increase in Neisseria meningitidis-Associated urethritis among men at two sentinel clinics, MMWR Morb Mortal Wkly Rep, vol.65, issue.21, pp.550-552, 2015. ,
Neisseria meningitidis ST11 complex isolates associated with nongonococcal urethritis, Emerg Infect Dis, vol.23, issue.2, pp.336-345, 2015. ,
Emergence of a new Neisseria meningitidis clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen, Proc Natl Acad Sci, vol.114, issue.16, pp.4237-4279, 2017. ,
Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles, BMC Genomics, vol.19, issue.1, p.176, 2018. ,
Large cluster of Neisseria meningitidis urethritis in Columbus, Clin Infect Dis, vol.65, issue.1, pp.92-101, 2015. ,
Rapid increase in gonorrhea cases with reduced susceptibility to azithromycin in Columbus, Sex Transm Dis, vol.45, issue.2, pp.5-6, 2018. ,
Heteroresistance to the model antimicrobial peptide polymyxin B in the emerging Neisseria meningitidis lineage 11.2 urethritis clade: mutations in the pilMNOPQ operon, Mol Microbiol, vol.111, issue.1, pp.254-68, 2019. ,
, Vaccine preventable diseases surveillance standards: World Health Organization, 2018.
, World Health Organization. Meningococcus: World Health Organization, 2018.
Meningococcal carriage and disease-population biology and evolution, Vaccine, vol.27, issue.2, pp.64-70, 2009. ,
Meningococcal carriage by age: a systematic review and meta-analysis, Lancet Infect Dis, vol.10, issue.12, pp.853-61, 2010. ,
The stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica, Epidemiol Infect, vol.99, issue.3, pp.591-601, 1987. ,
Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiol Infect, vol.123, issue.3, pp.349-57, 1999. ,
Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece, FEMS Immunol Med Microbiol, vol.39, issue.1, pp.23-32, 2003. ,
Prevention and control of meningococcal disease. Recommendations of the advisory committee on immunization practices (ACIP), MMWR Recomm Rep, vol.54, pp.1-21, 2005. ,
Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak, J Clin Microbiol, vol.33, issue.12, pp.3133-3140, 1995. ,
Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study, BMJ, vol.20, issue.0, pp.846-855 ,
Lessons from meningococcal carriage studies, FEMS Microbiol Rev, vol.31, issue.1, pp.52-63, 2007. ,
Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case-control study, Arch Dis Child, vol.83, issue.2, pp.117-138, 2000. ,
Complement deficiency states and meningococcal disease, Immunol Res, vol.12, issue.3, pp.295-311, 1993. ,
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria, N Engl J Med, vol.355, issue.12, pp.1233-1276, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00599451
Safety and efficacy of eculizumab in Guillain-Barre syndrome: a multicentre, double-blind, randomised phase 2 trial, Lancet Neurol, vol.17, issue.6, pp.519-548, 2018. ,
Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases, Curr Opin Pediatr, vol.25, issue.2, pp.225-256, 2013. ,
Risk of laboratory-acquired meningococcal disease, J Hosp Infect, vol.49, issue.4, pp.282-286, 2001. ,
No association between meningococcal disease and human immunodeficiency virus in adults in, Trans R Soc Trop Med Hyg, vol.85, issue.5, p.651, 1991. ,
Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study, BMC Med, vol.13, p.297, 2015. ,
Meningococcal disease and the complement system, Virulence, vol.5, issue.1, pp.98-126, 2014. ,
Infectious diseases associated with complement deficiencies, Clin Microbiol Rev, vol.4, issue.3, pp.359-95, 1991. ,
Emery and Rimoin's principles and practice of medical genetics, pp.1-13, 2013. ,
Strains responsible for invasive meningococcal disease in patients with terminal complement pathway deficiencies, J Infect Dis, vol.215, issue.8, pp.1331-1339, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02013257
Terminal complement component deficiencies in Japan, Exp Clin Immunogenet, vol.15, issue.4, pp.244-252, 1998. ,
,
, Pathol Microbiol, vol.27, pp.542-549, 1964.
Safe laboratory handling of Neisseria meningitidis, J Infect, vol.68, issue.4, pp.305-317, 2014. ,
Assessing the risk of laboratory-acquired meningococcal disease, J Clin Microbiol, vol.43, issue.9, pp.4811-4825, 2005. ,
An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, Euro Surveill, vol.21, issue.45, 2015. ,
, World Health Organization. Health of refugees and migrants. Regional situation analysis, practices, experiences, lessons learned and ways forward, 2018.
Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp, Trop Med Int Health, vol.1, issue.3, pp.385-92, 1996. ,
Meningococci of serogroup X clonal complex 181 in refugee camps, Italy. Emerg Infect Dis, vol.23, issue.5, pp.870-872, 2017. ,
Unal-Sahin N . A refugee patient with meningococcal meningitis type B, Hum Vaccin Immunother, vol.14, issue.9, p.2329, 2018. ,
A Syrian patient diagnosed with meningococcal meningitis serogroup B, Hum Vaccin Immunother, vol.10, issue.8, p.2482, 2014. ,
Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence, Pathog Glob Health, vol.111, issue.2, pp.59-68, 2017. ,
Rise in group W meningococcal carriage in university students, United Kingdom. Emerg Infect Dis, vol.23, issue.6, pp.1009-1020, 2017. ,
Molecular epidemiology of serogroup a meningitis in Moscow, Emerg Infect Dis, vol.7, issue.3, pp.420-427, 1969. ,
Department of public policy health statistics ,